Amgen Inc
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen Non-GAAP Cost of Sales as % of Product Sales by Quarter
Non-GAAP Cost of Sales as % of Product Sales (%) (%)
Amgen Non-GAAP Cost of Sales as % of Product Sales: 19.6% in Q2 2026, up 1.9 pts from a year earlier. That is the highest of the 36 quarters on record here.
Where the Q2 2026 figure comes from
“|| Non-GAAP cost of sales as a percentage of product sales | 19.6 | % | 17.7 | % | 19.6 | % | 17.9 | %”
Source: Form 8-K (amgn-20260630earningsrelea.htm, filed 2026-08-04) ↗
Reported in Form 8-K Reconciliations of GAAP to Non-GAAP Measures.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up non-GAAP Cost of Sales as % of Product Sales
Cite this data
StockData. (2026). Amgen Non-GAAP Cost of Sales as % of Product Sales (%), quarterly Q3 2017–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/ng-cogs-pct
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.